Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / CL A
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
26,963,661
-
Shares change
-
+232,477
-
Total reported value, excl. options
-
$883,834,810
-
Value change
-
+$16,924,688
-
Put/Call ratio
-
363%
-
Number of buys
-
64
-
Number of sells
-
-81
-
Price
-
$32.76
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q1 2022
198 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q1 2022.
REATA PHARMACEUTICALS INC - CL A (RETA) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,963,661 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,396,539 shares), CPMG Inc (2,896,901 shares), VANGUARD GROUP INC (2,643,082 shares), BlackRock Inc. (2,075,760 shares), EcoR1 Capital, LLC (1,975,611 shares), Camber Capital Management LP (1,500,000 shares), BOXER CAPITAL, LLC (1,239,000 shares), FRANKLIN RESOURCES INC (852,158 shares), STATE STREET CORP (668,018 shares), and DEUTSCHE BANK AG\ (632,758 shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.